View the LAMIVIR registration information details.
Back to drug list
ItemsDrug Registration information
ID2071
No2071
Brand NameLAMIVIR
IngredientsLAMIVUDINE USP 100 MG
Dosage FormTABLET
Primary PackagingALU-PVC BLISTER
Storage
Shelf Life3 YEARS
Pack SizeBOX OF 2 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsTREATMENT OF CHRONIC HEPATITIS B ASSOCIATED WITH EVIDENCE OF HEPATITIS B VIRAL REPLICATION AND ACTIVE LIVER INFLAMMATION
Contraindications
Side Effects
Unit Price
EDLNULL
Description ROUND SHAPED LIGHT PINK COLORED FILM COATED TABLET HAVING A BISECT LINE ON ONE SIDE
Note
License OwnerPALAMY PHARMA CO., LTD
ManufacturerINCEPTA PHARMACEUTICALS LIMITED
CountryBANGLADESH
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No05 I 3322/09
FDD Registration Date23/11/2023
Expiry Date22/11/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA